Retraction notice to "Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?"(Biomedicine & Pharmacotherapy, (2022), 154, C, (113522), (S0753332222009118), 10.1016/j.biopha.2022.113522)

Dhawan M.Saied A.R.A.Mitra S.Alhumaydhi F.A.Bin Emran T.Wilairatana P.Mahidol University2026-03-292026-03-292026-01-01Biomedicine and Pharmacotherapy (2026)07533322https://repository.li.mahidol.ac.th/handle/123456789/115868This article has been retracted: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article has been retracted at the request of the Editor. An investigation conducted on behalf of the journal by Elsevier's Research Integrity & Publishing Ethics team found that 12 citations were added to this paper at the author proof stage, without the approval of the Editor. The new citations were not immediately relevant to the topic of the paper and benefit authors, Talha Bin Emran and Manish Dhawan. The Editor has lost confidence in the results and conclusions of the article and has determined it should be retracted. The corresponding author did not respond to the retraction notice.Pharmacology, Toxicology and PharmaceuticsRetraction notice to "Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?"(Biomedicine & Pharmacotherapy, (2022), 154, C, (113522), (S0753332222009118), 10.1016/j.biopha.2022.113522)ErratumSCOPUS10.1016/j.biopha.2026.1192152-s2.0-10503304521019506007